A single mistranslated dosage instruction can delay a marketing authorisation, invalidate clinical trial data, or put a patient at risk. That is why life sciences translation compliance is a regulatory obligation rather than a quality extra. Every document that crosses a border, from a protocol to a package leaflet, must be accurate and traceable, and it must meet the rules of the authority reviewing it.
This guide covers the major regulatory frameworks, the documents they affect, and a practical approach to building translation workflows that hold up under inspection.
Why Compliance in Life Sciences Translation Is Different
General translation is judged on fluency and tone. Life sciences translation is judged on accuracy, consistency, traceability, and conformity to mandated formats. Regulators expect the translated document to be a faithful, auditable equivalent of the source.
The stakes explain why. Poor translation can lead to submission rejections, clinical holds, recalls, and in the worst cases, patient harm. Our article on the true cost of poor translation shows how quickly these risks become legal and financial exposure. In life sciences, they also become safety issues.
The Regulatory Landscape at a Glance
No single global rulebook governs life sciences translation. Requirements vary by region, product type, and document category. If you are mapping them country by country, our overview of regulatory considerations for medical translation across different countries is a good companion to this piece.
United States: FDA
The FDA expects foreign-language material in regulatory submissions to be accompanied by accurate English translations. For investigational new drug applications, 21 CFR 312.23 requires a complete and accurate English translation of any part of the application not in English.
Patient-facing documents have their own rule. Under 21 CFR 50.20, informed consent information must be given in language understandable to the subject. A literal but unreadable translation of a consent form fails this standard even if every word is technically correct.
Translation workflows that generate or store electronic records also need to consider 21 CFR Part 11, which governs electronic records and signatures.
European Union: EMA, CTR and MDR
The EU is where multilingual compliance becomes most demanding.
- Medicinal product information. For centrally authorised medicines, product information (the SmPC, package leaflet, and labelling) must follow the EMA’s QRD templates and go through linguistic review in all EU official languages, plus Icelandic and Norwegian. A translation that deviates from the template can be sent back regardless of linguistic quality.
- Clinical trials. The Clinical Trials Regulation (EU) No 536/2014 lets each Member State determine the language requirements for the application dossier and trial documents. Multinational trials therefore need a country-by-country language plan from day one.
- Medical devices. Under the Medical Device Regulation (EU) 2017/745, instructions for use, labels, and safety information must be provided in the language(s) determined by each Member State where the device is sold.
Global Clinical Research Standards
Most clinical research follows the principles of ICH Good Clinical Practice. The ICH E6(R3) revision, finalised in January 2025, introduced a more flexible, risk-based approach and was issued by the FDA as final guidance in September 2025. Regardless of how a sponsor implements it, the ethical foundation stays the same. The WMA Declaration of Helsinki requires that participants receive information they can genuinely understand, which makes accurate, culturally appropriate translation central to ethical research.
Document Types That Carry the Highest Compliance Risk
Not every document needs the same rigour, but these almost always do:
- Clinical trial documents: protocols, investigator brochures, informed consent forms, and patient diaries. See our guide to the role of localization in clinical trial documentation.
- Regulatory submissions: dossier components, labelling, SmPCs, and package leaflets.
- Patient-reported outcome (PRO) and clinical outcome assessment instruments: these need linguistic validation, not just translation (more below).
- Medical device documentation: IFUs, labelling, and technical files.
- Pharmacovigilance and safety reports: where timelines are legally fixed.
- Patient education materials: covered in depth in localization in patient education materials.
- Scientific publications and research papers: see translating medical research papers while maintaining scientific integrity.
The Quality Standards Behind Compliant Translation
Regulators rarely certify translation vendors, but sponsors are expected to use qualified, controlled processes. Three standards come up most often:
- ISO 17100 sets requirements for translation services, including translator qualifications and a mandatory revision step by a second linguist.
- ISO 18587 covers post-editing of machine translation output, which matters if you use machine translation anywhere in your workflow.
- ISO 13485 is the quality management standard for medical device manufacturers. It extends to outsourced processes, so device companies need to ensure their language vendors operate under adequate controls.
For a deeper look at how these map to regions, read our guide to medical translation, ISO compliance, and regulatory requirements by region.
Linguistic Validation: A Special Case
When a questionnaire or clinical outcome assessment is used across languages, a standard translation is not enough. The instrument must measure the same concept in every culture. The ISPOR Task Force principles of good practice describe a multi-step process that typically includes:
- Independent forward translations and reconciliation
- Back-translation
- Harmonisation across languages
- Cognitive debriefing with target-population respondents
- Proofreading and final reporting
Skipping steps here risks generating data that regulators will not accept as comparable across countries.
Data Privacy: The Compliance Layer People Forget
Life sciences documents routinely contain personal health data. Translation vendors that handle them become part of your data-protection chain. In the EU, the GDPR applies to this data, including special-category health data. In the US, HIPAA governs protected health information handled by covered entities and their business associates.
In practice this means signed confidentiality and data-processing agreements, secure file transfer, role-based access, and clear data retention and deletion rules. Our overview of legal compliance aspects of translation and localization covers the wider picture.
Using Technology Without Losing Control
Translation memory and terminology management are strong compliance tools. They enforce consistency across a product’s lifecycle, so a term approved in an SmPC stays the same in every label and update. We explain the cost and quality benefits in translation memory explained.
Machine translation is more nuanced. It can be appropriate for low-risk, internal-use content, but regulated and patient-facing text needs qualified human review. Before adopting it, read when to use MTPE instead of human translation and our comparison of AI translation vs. professional translation.
A Practical Compliance Checklist
Use this as a starting point for auditing your current process:
- Map requirements early. Identify target markets, applicable regulations, and language rules for each document type before translation begins.
- Use subject-matter-qualified linguists. Match translators to the therapeutic area and document type.
- Enforce a TEP workflow. Translation, editing, and proofreading by separate qualified people, consistent with ISO 17100.
- Control terminology. Maintain approved glossaries and translation memories per product.
- Follow mandated templates. Apply QRD and other regulatory formatting rules from the start.
- Validate where required. Use linguistic validation for PROs and COAs, and back-translation or independent review where authorities or sponsors expect it.
- Document everything. Keep an audit trail covering who translated, reviewed, and approved each version, and when.
- Protect patient data. Confirm confidentiality, security, and data-processing terms with every vendor.
- Plan for certification. Know in advance when a certified or notarised translation is needed. Our guide to certified vs. notarized vs. sworn translation explains the differences.
- Audit your vendor. Ask the hard questions before you sign. See how to choose a translation agency.
Frequently Asked Questions (FAQs)
Do regulators require a specific translation certification?
Usually not for the vendor itself. They require that the translation be accurate and complete, and that documentation be available. Certified or notarised translations are required only in specific cases, such as certain national filings. Adopting ISO 17100 processes is widely seen as good evidence of control.
Can machine translation be used for regulatory documents?
It can support productivity in low-risk contexts, but patient-facing, safety-critical, and submission documents need qualified human translation and review.
What is the biggest cause of translation-related submission delays?
Template non-conformity, inconsistent terminology between documents, and last-minute translation planning are the most common avoidable causes.
Is linguistic validation the same as translation?
No. Linguistic validation is a structured, multi-step process designed to confirm that a translated instrument measures the same concept in a new culture.
Final Thoughts
Life sciences translation compliance rests on three things: knowing the rules of each market, building a controlled and documented workflow, and working with linguists who understand both the language and the science. Done well, it shortens approval timelines and protects patients.
Ekitai Solutions provides medical translation services backed by qualified linguists and strict confidentiality practices, along with technical translation for device manuals and specifications and wider localization services for global launches. Talk to our team about an audit-ready translation workflow for your next submission.
This article is for general information and does not constitute legal or regulatory advice. Always confirm requirements with the relevant authority or your regulatory affairs team.
Related Articles
- Navigating the Complexities of Life Sciences Localization
- Medical Translation, ISO Compliance & Regulatory Requirements by Region
- Regulatory Considerations for Medical Translation Across Different Countries
- The Role of Localization in Clinical Trial Documentation
- Ensuring Accuracy in Medical Document Translation: Challenges and Solutions
- The Importance of Localization in Patient Education Materials
